InsidersTradesSigma
Track the Fisher & Paykel Healthcare Corporation Limited share price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, Fisher & Paykel Healthcare Corporation Limited has published 1 reports. Market capitalisation: €21bn. The latest transaction was filed on 18 May 2026 (Initial Substantial Holding). Every trade is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Fisher & Paykel Healthcare Corporation Limited Buy (bullish), based on 9 analysts. Average price target: A$36.92.
Fundamental score
Ranked 8,753 of 29,063 companies
61.4
score / 100
Value37
Quality86
FCF yld2.2%
Earn yld2.2%
EV/EBITDA27.0x
ROE23%
Gross mgn64%
Net mgn20%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 May 2026
Acerca de Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited es una empresa neozelandesa que se especializa en el diseño y la fabricación de dispositivos médicos para aplicaciones respiratorias y de anestesia. Cotiza en el mercado XASX.